203 related articles for article (PubMed ID: 16244265)
1. Salivary gland tumors at in vivo proton MR spectroscopy.
King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.
Yabuuchi H; Fukuya T; Tajima T; Hachitanda Y; Tomita K; Koga M
Radiology; 2003 Feb; 226(2):345-54. PubMed ID: 12563124
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors.
Sumi M; Van Cauteren M; Sumi T; Obara M; Ichikawa Y; Nakamura T
Radiology; 2012 Jun; 263(3):770-7. PubMed ID: 22447854
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.
Hisatomi M; Asaumi J; Yanagi Y; Unetsubo T; Maki Y; Murakami J; Matsuzaki H; Honda Y; Konouchi H
Oral Oncol; 2007 Oct; 43(9):940-7. PubMed ID: 17257881
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
[TBL] [Abstract][Full Text] [Related]
8. Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T.
King AD; Yeung DK; Ahuja AT; Yuen EH; Ho SF; Tse GM; van Hasselt AC
Clin Radiol; 2005 May; 60(5):592-8. PubMed ID: 15851048
[TBL] [Abstract][Full Text] [Related]
9. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
[TBL] [Abstract][Full Text] [Related]
10. Adrenal masses: characterization with in vivo proton MR spectroscopy--initial experience.
Faria JF; Goldman SM; Szejnfeld J; Melo H; Kater C; Kenney P; Huayllas MP; Demarchi G; Francisco VV; Andreoni C; Srougi M; Ortiz V; Abdalla N
Radiology; 2007 Dec; 245(3):788-97. PubMed ID: 18024453
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
[TBL] [Abstract][Full Text] [Related]
12. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
13. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
[TBL] [Abstract][Full Text] [Related]
14. Human breast lesions: characterization with proton MR spectroscopy.
Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
[TBL] [Abstract][Full Text] [Related]
15. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
16. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
18. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
[TBL] [Abstract][Full Text] [Related]
19. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
[TBL] [Abstract][Full Text] [Related]
20. MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors.
Eida S; Ohki M; Sumi M; Yamada T; Nakamura T
J Magn Reson Imaging; 2008 Jun; 27(6):1256-62. PubMed ID: 18504743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
